Back

Prognostic impact of atrial fibrillation in patients undergoing primary PCI with versus without left ventricular function impairment

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Prognostic Impact of Percutaneous Coronary Interventions Outcome ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Andrija Pavlovic

University Children's Hospital of Belgrade, Belgrade (Serbia)

7 More presentations in this session

Presentation thumbnail
Optimal timing of delayed percutaneous coronary intervention in stable patients with ST-segment elevation myocardial infarction
Doctor Q. Zhao (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of a CTO in a non-infarct-related artery on long-term mortality in patients undergoing primary PCI
Doctor D. Milasinovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Impact of early (<24h) versus delayed (>24h) intervention in patients with non ST segment elevation myocardial infarction (an observational study of 20882 patients)
Doctor V. Panoulas (Harefield, Uxbridge, GB)
Abstract Slides Video
Presentation thumbnail
Ischemic burden reduction after chronic total occlusion percutaneous coronary intervention related to patient prognosis
Mr S. Schumacher (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Treatment of complex coronary artery disease in patients with diabetes mellitus and chronic kidney disease: 10-year results comparing outcomes of CABG and PCI in the SYNTAXES trial
Doctor C. Gao (Xi'an, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostic Impact of Percutaneous Coronary Interventions

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease
thumbnail
Congress Presentation
Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources